Obstetrics & Gynecology Doctors in El Cajon, CA Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Rhett Papa, D.O. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 133 W Main St, El Cajon, CA 92020 Phone: 310-990-9908

Dr. Niloufer Siddiqui Dennis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 330 S Magnolia Ave, Suite 301, El Cajon, CA 92020 Phone: 800-395-9431    Fax: 888-502-8290

Aliya I Khan, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1032 Broadway, Ob-gyn, El Cajon, CA 92021 Phone: 619-795-5991    Fax: 619-795-5992

Mrs. Marissa Lyn Brown, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 250 Travelodge Drive, El Cajon, CA 92020 Phone: 619-528-5000

Mary Loraine Sullivan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 133 W Main St # 240, El Cajon, CA 92020 Phone: 619-401-0404

Austin M. Kooba, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 S Magnolia Ave Ste 301, El Cajon, CA 92020 Phone: 858-353-3945

News Archive

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

MiCardia® today announced that The United States Patent Office granted patent number US7,594,887 B2, "Shape Memory Devices and Methods for Reshaping Heart Anatomy," on September 29th, 2009.

Full results from Derma Sciences' DSC127 Phase 2 trial on diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that full results from its successful Phase 2 clinical trial with the investigational drug DSC127 in patients with diabetic foot ulcers will be published on July 5th in the July 2012 issue of Wound Repair and Regeneration.

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.

Study uncovers impact of both low and high iron counts

A global study looking at the role that iron plays in 900 diseases has uncovered the impact of both low and high iron counts – and the news is mixed.

Research shows how the brain repurposes unused regions in blind people

In adults that are born blind, the "visual" cortex is activated in a similar way during a listening task, according to new research in JNeurosci.

Read more Medical News

› Verified 9 days ago